0 antall prosjekter

PES-HORISONT-EU-PES Horisont Europa

Chemo-Immunotherapy through Accelerated Uptake

This PES project will highlight the proposal's potential on the radical innovativeness of the emerging cancer patient-centric chemoimmunotherapy developing platform technology for accelerated active pharma ingredient uptake. Malignant solid tumours are challenging to treat due to their poor and i...

Tildelt: kr 49 999

Prosjektperiode: 2022-2022

Sted: Oslo

PES2020-Prosj.etabl.støtte H2020

AEDUST: Accelerated and Enhanced Drug Uptake for Solid Tumours

iNANOD is currently developing a platform technology that will facilitate and improve drug delivery into solid tumours of diagnosed cancer patients. Our platform takes upon existing promising solutions that are currently used separately, and therefore lack the full potential therapeutic effect th...

Tildelt: kr 99 999

Prosjektperiode: 2020-2020

Sted: Oslo

PES2020-Prosj.etabl.støtte H2020

Fast and Active-targeted Encapsulated Metal Drugs Against Cancer

iNANOD AS is a biotech company focusing on developing a new generation of metal encapsulated nano-sized anticancer drugs. Upon desired successful combination of the technology, it will allow faster and targeted delivery of anticancer drugs to tumours, improving drug efficacy and reducing side ef...

Tildelt: kr 49 999

Prosjektperiode: 2018-2018

Sted: Oslo

NANO2021-Nanoteknologi og nye materiale

Fast and Active-targeted Encapsulated Metal Drugs Against Cancer

iNANOD AS is a biotech company focusing on developing a new generation of metal encapsulated nano-sized anticancer drugs. Upon desired successful combination of the technology, it will allow faster and targeted delivery of anticancer drugs to tumours, improving drug efficacy and reducing side ef...

Tildelt: kr 0,20 mill.

Prosjektperiode: 2017-2018

Sted: Oslo